Načítá se...
Sorafenib for the Treatment of Hepatocellular Carcinoma: A Single-centre Real-world Study
BACKGROUND: Sorafenib is an oral multi-kinase inhibitor used for the treatment of hepatocellular carcinoma. Its efficacy in randomised controlled trials was demonstrated in patients with well-preserved liver function and good functional status. In the real-world setting, treatment is often offered t...
Uloženo v:
| Vydáno v: | Radiol Oncol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Sciendo
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7276638/ https://ncbi.nlm.nih.gov/pubmed/32463391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2020-0027 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|